Floatz logo

Iodixanol

Sarcopenia

Nemocnice AGEL Trinec-Podlesi a.s.Small moleculeActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
89/ 100

Competitive context

3 Active assets in the Sarcopenia cohort.

Asset / SponsorPhaseRating
Theprubicin
Sohag University
D
Ethiodized Oil
Sohag University
D
METAMIZOLE
Central Taiwan University of Science and Technology
N/AD
Humulin R
University of Nottingham
N/AD
NEPENTHE
Central Taiwan University of Science and Technology
N/AD
DEXKETOPROFEN
Central Taiwan University of Science and Technology
N/AD
Alpha Tocopherol
University of Ioannina
N/AD
PANITUMUMAB
Consorci Sanitari del Maresme
N/AD

Same molecule, other indications

Iodixanol is also rated in:

carotid stenosisDormant
B
Indicative ·
63 / 100
View asset →
atherosclerosisDormant
B
Indicative ·
62 / 100
View asset →
Colon CancerDormant
B
Indicative ·
59 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →